Biotechnology Stocks I: Returns for ARS Pharmaceuticals, Inc. (SPRY)
SPRY has no dividends.
Table and Chart of SPRY Performance
See what a $1,000 investment in SPRY is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| SPRY Returns | |
|---|---|
| Start Date | Jan-29-2021 |
| Start Price | $43.92 |
| End Date | Dec-10-2024 |
| End Price | $12.95 |
| # Prices | 48 |
| Min Date | Apr-29-2022 |
| Min Price | $3.11 |
| Max Date | Feb-26-2021 |
| Max Price | $48.06 |
| Total Return | -70.51% |
| Annualized Return | -26.31% |
| Current Value of $1,000 Purchase | $295 |
| Number Returns | 1,128 |
| Average Return | 12.95% |
| Number Profitable Returns | 563 |
| Percent Profitable Returns | 49.91% |
| Number Unprofitable Returns | 565 |
| Percent Unprofitable Returns | 50.09% |
| Profitable to Unprofitable Returns Ratio | 1.00 |
| SPRY Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -9.880 | Price to Sales | 0.00 |
| Earnings per Share | $0.0000 |
| PE Ratio | -60444000 |
| PE to Growth Ratio | None |
| Price to Book | 503.71 |
| PRICE DATA | |
| 52 Week High | $0.998 |
| 52 Week Low | $18.51 |
| Analyst Target Price | $49 |
| 50-Day Moving Average | $5.02 |
| 200-Day Moving Average | $14.79 |
| FINANCIAL DATA | |
| Revenue per Share | $-0.5 |
| Revenue | $0 |
| Profit Margin | 2.7% |
| Return on Equity | -16.2% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
SPRY Compare Returns with S&P 500
SPRY Trendline Chart
SPRY Moving Average Chart
SPRY Stock Return Map - See Patterns of Gains and Losses
SPRY Stock Returns/Purchase Dates